Conquer Cancer Foundation of the American Society of Clinical Oncology

Mission: Accelerate breakthroughs in lifesaving research and empower people everywhere to conquer cancer.

Vision: A world where cancer is prevented or cured, and every survivor is healthy.

Conquer Cancer was created by the American Society of Clinical Oncology (ASCO) to fund research for every type of cancer, everywhere in the world.

Through research grants and other awards, we make it possible for oncology researchers to advance discoveries needed by patients to conquer cancer. We are the only cancer foundation backed by the expertise of the world's leading cancer professionals—the most TRUSTED and CREDIBLE source of cancer knowledge, education and information. Through networks and programs reaching more than 100 countries., we also foster the sharing of information to help oncology professionals improve care for patients.

Conquer Caner seeks to conquer cancer through funding research grants and the education initiatives of the American Society of Clinical Oncology (ASCO).Our Grants and Awards Program provides essential funding to researchers both domestically and internationally at every career state. We continue to grow the number of grant recipients each year to further advance research.

In 2019, ASCO debuted a set of priorities, established by panel of experts in different oncology subspecialties, as well as cancer prevention, quality of care, and health disparities, to accelerate progress against cancer. The research priorities identified address vital, unmet needs and help fill knowledge gaps in areas critical to improving patient care. Conquer Cancer will work to support research funding for these priorities, in addition to disease-specific grants established through endowed awards and donor-designated support.

In addition to funding research grants and awards, Conquer Cancer supports ASCO's award winning website Cancer.Net (consumer cancer website of over 120 cancers), which provides resources for patients and families, as well as patient waiting room materials and survivor/advocate programs. Conquer Cancer also actively supports ASCO's CancerLinQ project, which is a cutting-edge health information technology (HIT) platform designed to aggregate and analyze a massive web of real-world cancer data. Through this platform, oncologists around the world will have the opportunity to better learn, treat and improve the quality of cancer care for all. In addition to the programs noted above, Conquer Cancer supports several other ASCO programs, including those focused on reducing disparities in access to care, ensuring a diverse, well-trained workforce, and improving cancer care internationally.

ASCO's diverse network of nearly 45,000 oncology professionals, approximately 30% of whom reside internationally, representing more than 120 countries, are touched daily by the ongoing support of Conquer Cancer Eighty-four cents of every dollar donated to Conquer Cancer goes toward programs that directly impact people living with cancer. The work we support touches every person with cancer. Conquer Cancer and ASCO are committed to defeating all forms of cancer, including the rare ones. And Conquer Cancer is one of only a few organizations committed to supporting research across all types of cancers.

With a network that is global in its scope, ASCO's creditability in the field of cancer is exceptional, thereby giving Conquer Cancer the ability to work with, and call upon, just about anyone in the field. ASCO members are the most trusted and credible sources of cancer knowledge, education, and information in the world. Through Conquer Cancer, we are training physicians on the latest advances and investing in the next generation of cancer research by funding promising careers and outstanding research.

While cancer continues to be one of the most significant global health problems, Conquer Cancer is doing its part. To date, 2,400 grants totaling more than $146 million have been awarded to cancer researchers to investigators in more than 78 countries. Since 1984. 98 percent of the researchers Conquer Cancer has supported still work in cancer research today, many of whom have gone on to make significant advances in the treatment and care of patients with cancer.

Conquer Cancer researchers continue to lead the way in important breakthroughs. The work of nine researchers who previously received early-career funding from Conquer Cancer are featured in Clinical Cancer Advances 2019: ASCO's Annual Report on Progress Against Cancer. This independent review of the field, now in its 14th year, showcases major breakthroughs in clinical cancer research and care, as well as emerging trends in oncology.

In 2019, ASCO debuted a set of priorities, established by panel of experts in different oncology subspecialties, as well as cancer prevention, quality of care, and health disparities, to accelerate progress against cancer. The research priorities identified address vital, unmet needs and help fill knowledge gaps in areas critical to improving patient care. Conquer Cancer will work to support research funding for these priorities.